{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:36:05Z","timestamp":1792146965100,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.3816\/clm.2008.n.053","type":"journal-article","created":{"date-parts":[[2008,12,9]],"date-time":"2008-12-09T03:09:43Z","timestamp":1228792183000},"page":"359-362","source":"Crossref","is-referenced-by-count":12,"title":["Schnitzler's Syndrome: Increased Levels of Bone Formation and Angiogenesis Factors Are Reduced After Successful Pefloxacin Treatment"],"prefix":"10.3816","volume":"8","author":[{"given":"Efstathios","family":"Kastritis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Katoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Panayiotides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gavriatopoulopu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios A.","family":"Dimopopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2008.n.053_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","article-title":"Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment","volume":"37","author":"de Koning","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.3816\/CLM.2008.n.053_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200101000-00004","article-title":"The Schnitzler syndrome. Four new cases and review of the literature","volume":"80","author":"Lipsker","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.3816\/CLM.2008.n.053_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1468-3083.2002.00458.x","article-title":"Schnitzler's syndrome: what's new?","volume":"16","author":"Almerigogna","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.3816\/CLM.2008.n.053_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2141.2007.06609.x","article-title":"Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity","volume":"137","author":"Anagnostopoulos","year":"2007","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2008.n.053_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2141.2006.06017.x","article-title":"Abnormal bone remodelling and increased levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) in Waldenstrom macroglobulinaemia","volume":"133","author":"Terpos","year":"2006","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2008.n.053_bib6","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/archderm.143.8.1046","article-title":"Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin","volume":"143","author":"Asli","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2008.n.053_bib7","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1038\/sj.leu.2403890","article-title":"The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory\/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL\/osteoprotegerin ratio","volume":"19","author":"Terpos","year":"2005","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2008.n.053_bib8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1046\/j.1365-2133.2000.03477.x","article-title":"Schnitzler syndrome: heterogeneous immunopathological findings involving IgM-skin interactions","volume":"142","author":"Lipsker","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.3816\/CLM.2008.n.053_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0091-6749(91)90335-L","article-title":"Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition\u2013higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia)","volume":"88","author":"Saurat","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"10.3816\/CLM.2008.n.053_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.2005.045245","article-title":"Beneficial response to anakinra and thalidomide in Schnitzler's syndrome","volume":"65","author":"de Koning","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.3816\/CLM.2008.n.053_bib11","first-page":"931","article-title":"Treatment of Schnitzler's syndrome with anakinra","volume":"25","author":"Gilson","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.3816\/CLM.2008.n.053_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2340\/00015555-0233","article-title":"Striking effect of the IL-1 receptor antagonist anakinra in chronic urticarial rash with polyclonal increase in IgA and IgG","volume":"87","author":"Treudler","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.3816\/CLM.2008.n.053_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaad.2007.03.036","article-title":"Schnitzler syndrome: treatment failure to rituximab but response to anakinra","volume":"57","author":"Eiling","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2008.n.053_bib14","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.jaad.2006.05.057","article-title":"Prompt response of refractory Schnitzler syndrome to treatment with anakinra","volume":"56","author":"Schneider","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2008.n.053_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1440-0960.2007.00375.x","article-title":"Schnitzler's syndrome: successful treatment with anakinra","volume":"48","author":"Crouch","year":"2007","journal-title":"Australas J Dermatol"},{"key":"10.3816\/CLM.2008.n.053_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1610-0387.2008.06627.x","article-title":"The Schnitzler syndrome: Chronic urticaria and monoclonal gammopathy-an autoinflammatory syndrome?","volume":"6","author":"Eiling","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.3816\/CLM.2008.n.053_bib17","article-title":"Schnitzler syndrome: a dramatic improvement with anakinra","author":"Wastiaux","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.3816\/CLM.2008.n.053_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1346-8138.1995.tb03337.x","article-title":"A case of urticarial vasculitis associated with macroglobulinemia (Schnitzler's syndrome)","volume":"22","author":"Morita","year":"1995","journal-title":"J Dermatol"},{"key":"10.3816\/CLM.2008.n.053_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0300-2977(97)00041-7","article-title":"Schnitzler's syndrome presenting as fever of unknown origin (FUO). The role of cytokines in its systemic features","volume":"51","author":"de Kleijn","year":"1997","journal-title":"Neth J Med"},{"key":"10.3816\/CLM.2008.n.053_bib20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/annonc\/mdi235","article-title":"Myeloma bone disease: pathophysiology and management","volume":"16","author":"Terpos","year":"2005","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2008.n.053_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3816\/CLM.2006.n.043","article-title":"Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support","volume":"7","author":"Kastritis","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.3816\/CLM.2008.n.053_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1473-3099(03)00658-3","article-title":"Immunomodulatory effects of quinolones","volume":"3","author":"Dalhoff","year":"2003","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T19:12:09Z","timestamp":1684782729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011702645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1557919011702645"],"URL":"https:\/\/doi.org\/10.3816\/clm.2008.n.053","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}